Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breaking the guardian of the genome: TP53 dysfunction in myeloid neoplasms.

Biochemical pharmacology·2026
Same author

Enhancing the Catalytic Performance of Zeolites via Metal Doping and Porosity Control.

Molecules (Basel, Switzerland)·2025
Same author

Interface dermatitis in a patient with TRNT1 deficiency: A case report.

JAAD case reports·2025
Same author

Child With Painful Purpuric Rash of the Hands and Feet.

Pediatric dermatology·2025
Same author

Multifunctional Catalysts for Cascade Reactions in Biomass Processing.

Nanomaterials (Basel, Switzerland)·2024
Same author

Use of Albumin In Situ Hybridization to Diagnose Cutaneous Metastatic Hepatocellular Carcinoma With Poorly Differentiated Features: A Case Report and Review of the Literature.

The American Journal of dermatopathology·2024

Related Experiment Video

Updated: Jul 17, 2026

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique
06:47

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique

Published on: September 20, 2011

37.6K

Utilizing Stimuli Responsive Linkages to Engineer and Enhance Polymer Nanoparticle-Based Drug Delivery Platforms.

Kian K Hershberger1, Andrew J Gauger1, Lyudmila M Bronstein1,2,3

  • 1Indiana University, Department of Chemistry, Bloomington, 800 East Kirkwood Avenue, Indiana 47405, United States.

ACS Applied Bio Materials
|January 10, 2022
PubMed
Summary

Scientists are developing smart drug delivery systems that release chemotherapy drugs only at cancer sites. This targeted approach minimizes damage to healthy tissues, improving cancer treatment effectiveness and reducing side effects.

Keywords:
disassemblydrug delivery platformslinkagesnanoparticleresponsive

More Related Videos

Nanosponge Tunability in Size and Crosslinking Density
11:15

Nanosponge Tunability in Size and Crosslinking Density

Published on: August 4, 2017

7.8K
Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

1.3K

Related Experiment Videos

Last Updated: Jul 17, 2026

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique
06:47

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique

Published on: September 20, 2011

37.6K
Nanosponge Tunability in Size and Crosslinking Density
11:15

Nanosponge Tunability in Size and Crosslinking Density

Published on: August 4, 2017

7.8K
Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

1.3K

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Materials Science

Background:

  • Cancer remains a leading global cause of death, with chemotherapy being a primary treatment modality.
  • Chemotherapy's efficacy is often limited by severe adverse effects due to damage to healthy tissues and organs.
  • Targeted drug delivery systems aim to mitigate these side effects by controlling therapeutic agent distribution.

Purpose of the Study:

  • To review the integration of stimuli-responsive linkages in targeted drug delivery systems for enhanced cancer therapy.
  • To explore how these systems control the release of anticancer agents specifically at the tumor site.
  • To summarize the design principles and mechanisms of stimuli-responsive drug delivery platforms.

Main Methods:

  • Discussion of stimuli-responsive components like cross-linkers, polymers, and surface modifications within drug delivery vessels.
  • Analysis of how environmental and external stimuli trigger drug release mechanisms.
  • Examination of the resulting changes in drug delivery platforms, including disassembly and altered cellular uptake.

Main Results:

  • Stimuli-responsive elements enable drug release exclusively at the target site upon exposure to specific triggers.
  • These responsive components lead to controlled disassembly, morphological changes, or enhanced cellular uptake of the delivery system.
  • The targeted release confines toxic therapeutic agents to the affected area, minimizing systemic toxicity.

Conclusions:

  • Stimuli-responsive drug delivery systems offer a promising strategy to improve the therapeutic index of chemotherapy.
  • By precisely controlling drug release, these platforms can significantly reduce the debilitating side effects of cancer treatment.
  • Further development in this area holds potential for more effective and safer cancer therapies.